This study is testing an experimental vaccine called ACI-7104.056 in people with early Parkinson's disease. The main goals are to check if the vaccine is safe and to see if it triggers an immune response against a harmful brain protein linked to Parkinson's. About 150 participant…
Phase: PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC